Safety and Bioequivalence of Pimecrolimus Cream 1% and Elidel R in Treatment of Mild to Moderate Atopic Dermatitis
Phase 3
Completed
- Conditions
- Atopic Dermatitis
- Interventions
- First Posted Date
- 2017-09-29
- Last Posted Date
- 2017-09-29
- Lead Sponsor
- Par Pharmaceutical, Inc.
- Target Recruit Count
- 582
- Registration Number
- NCT03297502
Bioequivalence of Two Ciprofloxacin 0.3%/Dexamethasone 0.1% Sterile Otic Suspensions in Otitis Media in Children With Tympanostomy Tubes
Phase 3
Terminated
- Conditions
- Otitis Media in Patients With Tympanostomy Tubes
- Interventions
- Drug: Placebo Sterile Otic Suspension
- First Posted Date
- 2013-11-26
- Last Posted Date
- 2017-09-26
- Lead Sponsor
- Par Pharmaceutical, Inc.
- Target Recruit Count
- 203
- Registration Number
- NCT01994642
- Locations
- 🇺🇸
Birmingham Pediatrics, Birmingham, Alabama, United States
🇺🇸Agave Clinical Ressearch, Mesa, Arizona, United States
🇺🇸Arizona Center for Clinical Trials, Phoenix, Arizona, United States
A Bioequivalence Study of Two Ciprofloxacin/Dexamethasone Formulations in Patients With Otitis Externa
Phase 3
Terminated
- Conditions
- Otitis Externa
- Interventions
- First Posted Date
- 2013-07-29
- Last Posted Date
- 2016-10-18
- Lead Sponsor
- Par Pharmaceutical, Inc.
- Target Recruit Count
- 455
- Registration Number
- NCT01910155
- Locations
- 🇺🇸
James Donivan Gordon, MD, Tucson, Arizona, United States
🇺🇸Nea Baptist Clinic, Jonesboro, Arkansas, United States
🇺🇸Applied Reserch Center, Little Rock, Arkansas, United States
Bioequivalence Study of Doxycycline Monohydrate Tablets Under Fed Conditions
Phase 1
Completed
- Conditions
- To Determine Bioequivalence Under Fed Conditions
- Interventions
- First Posted Date
- 2011-06-27
- Last Posted Date
- 2017-09-26
- Lead Sponsor
- Par Pharmaceutical, Inc.
- Target Recruit Count
- 24
- Registration Number
- NCT01380496
- Locations
- 🇨🇦
Anapharm Inc., Sainte-Foy, Quebec, Canada
Bioavailability Study of Dronabinol Capsules 10 mg Under Fasting Conditions
Phase 1
Completed
- Conditions
- To Determine Bioequivalence Under Fasting Conditions
- Interventions
- First Posted Date
- 2011-06-27
- Last Posted Date
- 2011-06-27
- Lead Sponsor
- Par Pharmaceutical, Inc.
- Target Recruit Count
- 69
- Registration Number
- NCT01380457
- Locations
- 🇺🇸
BASi, Baltimore, Maryland, United States
A Comparative Bioavailability Study of Lisinopril Tablets, 40 mg - Effect of Food Study
Phase 1
Completed
- Conditions
- To Determine Bioequivalence Under Fed Conditions
- Interventions
- First Posted Date
- 2011-06-27
- Last Posted Date
- 2011-06-27
- Lead Sponsor
- Par Pharmaceutical, Inc.
- Target Recruit Count
- 18
- Registration Number
- NCT01380431
- Locations
- 🇺🇸
PharmaKinetics Laboratories, Inc., Baltimore, Maryland, United States
Bioavailability Study of Metronidazole Capsules Under Fed Conditions
Phase 1
Completed
- Conditions
- To Determine the Bioequivalence Study Under Fed
- Interventions
- First Posted Date
- 2011-06-27
- Last Posted Date
- 2011-06-27
- Lead Sponsor
- Par Pharmaceutical, Inc.
- Target Recruit Count
- 18
- Registration Number
- NCT01380522
- Locations
- 🇨🇦
Algorithme Pharma Inc, Montreal, Quebec, Canada
Bioavailability Study of Metronidazole Capsules Under Fasting Conditions
Phase 1
Completed
- Conditions
- To Determine the Bioequivalence Study Under Fasting
- Interventions
- First Posted Date
- 2011-06-27
- Last Posted Date
- 2011-06-27
- Lead Sponsor
- Par Pharmaceutical, Inc.
- Target Recruit Count
- 28
- Registration Number
- NCT01380509
- Locations
- 🇨🇦
Algorithme Pharma, Laval, Quebec, Canada
Bioequivalence Study of Doxycycline Monohydrate Tablets Under Fasting Conditions
Phase 1
Completed
- Conditions
- To Determine Bioequivalence Under Fasting Conditions
- Interventions
- First Posted Date
- 2011-06-27
- Last Posted Date
- 2011-06-27
- Lead Sponsor
- Par Pharmaceutical, Inc.
- Target Recruit Count
- 40
- Registration Number
- NCT01380483
- Locations
- 🇨🇦
Anapharm Inc., Sainte-Foy, Quebec, Canada
Comparative Bioavailability Study of Lisinopril Tablets, 10 mg
- First Posted Date
- 2011-06-17
- Last Posted Date
- 2011-06-17
- Lead Sponsor
- Par Pharmaceutical, Inc.
- Target Recruit Count
- 36
- Registration Number
- NCT01375244
- Locations
- 🇺🇸
PharmaKinetics Laboratories, Inc., Baltimore, Maryland, United States